Status:
UNKNOWN
Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation
Lead Sponsor:
Komagome Hospital
Conditions:
Gastrointestinal Neoplasms
Eligibility:
All Genders
20-70 years
Brief Summary
The purpose of this study is to clarify the relationship bone marrow-derived cells and the formation of the tumors, and the role of these cells in regeneration of epithelial cells in the gastrointesti...
Detailed Description
Recent experimental studies showed that circulating bone marrow-derived stem cells contribute to the formation of cancers cells. However, it is not clear whether this is applicable to human beings or ...
Eligibility Criteria
Inclusion
- After allogeneic bone marrow transplantation
Exclusion
- Contraindication for gastrointestinal endoscopy
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00452205
Start Date
April 1 2007
End Date
March 1 2017
Last Update
August 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer and Infection Disease Center, Komagome
Tokyo, Bunkyo-ku, Japan, 113-8677